scispace - formally typeset
Y

Yann Cormerais

Researcher at Harvard University

Publications -  19
Citations -  882

Yann Cormerais is an academic researcher from Harvard University. The author has contributed to research in topics: Cancer cell & mTORC1. The author has an hindex of 12, co-authored 19 publications receiving 632 citations.

Papers
More filters
Journal ArticleDOI

Genetic ablation of the cystine transporter xCT in PDAC cells inhibits mTORC1, growth, survival and tumor formation via nutrient and oxidative stresses

TL;DR: In vitro pharmacological inhibition of xCT by low concentrations of erastin phenocopied xCT-KO and potentiated the cytotoxic effects of both gemcitabine and cisplatin in PDAC cell lines strongly support that inhibition ofxCT, by its dual induction of nutritional and oxidative cellular stresses, has great potential as an anticancer strategy.
Journal ArticleDOI

The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5)

TL;DR: ASCT2KO reduces tumor growth by limiting AA import, but that this effect is independent of LAT1 activity, which indicates that the proposed functional coupling model of ASCT2 and LAT1 is not universal across different cancer types.
Journal ArticleDOI

Hypoxia and cellular metabolism in tumour pathophysiology.

TL;DR: Evidence is provided for a number of hypoxia‐induced proteins that promote cellular anabolism and regulation of metabolic acid–base levels in tumour cells including amino‐acid transporters (LAT1), monocarboxylatetransporters, and acid– base regulating carbonic anhydrases (CAs) and bicarbonate transportters (NBCs).
Journal ArticleDOI

Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux

TL;DR: A new therapeutic approach is proposed combining sunitinib with molecules that prevent lysosomal accumulation or inhibit the proteasome to maintain a cellular homeostasis of mRCC.